-
Forward Look
Fine-Tuning Treatments for Triple-Negative Breast CancerStudies aim to identify best available treatments and find new ones.
by Cameron Walker
-
The Power of 1Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
-
Healthy Habits
What’s The Beef?Get the facts about meat consumption and cancer risk.
by Brenda Conaway
-
From the Editor-in-Chief
Early-Stage Prostate Cancer: To Treat or Not To TreatStrategies for prostate cancer screening and surveillance are still being refined.
by William G. Nelson, MD, PhD
-
Forward Look
Should the Age to Buy Cigarettes Be 21?Q&A with CDC's Brian King on reducing teen access to tobacco products.
by Chris Palmer
-
Forward Look
Reducing Re-excisionNew guidelines and techniques aim to limit additional breast cancer surgeries.
by Kendall K. Morgan
-
-
Forward Look
Uterine Cancer Rates on the RiseStudy finds deaths are highest among African-American women.
by Brenda Conaway
-
Forward Look
Cancer Immunotherapies Continue to Make HeadwayDrugs that harness the power of the immune system gain new approvals.
by Alexandra Goho
-
Big Data: Sharing Information to Improve CareBig data, using high-powered computers to gather and analyze massive amounts of patient information, promises to revolutionize cancer care. But experts say patient concerns about privacy and other issues must be addressed.
by Stephen Ornes
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
